Skip to main content

Table 4 Participants’ knowledge about the healthcare system for RD patients

From: Needs assessment study of rare diseases education for nurses and nursing students in Poland

Items

Students

N(%)

Nurses

N(%)

p - value

What is the name of the European website providing information about RD and orphan drugs?

  

0

 Rare Disease Foundation

3 (2.7)

6 (3.9)

 

 NORD

4 (3.5)

1 (0.7)

 

 EURORDIS

11 (9.7)

29 (18.7)

 

 R.A.R.E

5 (4.4)

5 (3.2)

 

Orphanet

1 (0.9)

28 (18.1)

 

 Global Genes

1 (0.9)

3 (1.9)

 

 I do not know

88 (77.9)

83 (53.5)

 

Is there a central register of RD patients in Poland?

  

0.31

 Yes

64 (56.6)

100 (64.5)

 

No

10 (8.9)

8 (5.2)

 

 I do not know

39 (34.5)

47 (30.3)

 

What percentage of rare disease can be treated with drugs?

  

0.14

 0%

6 (5.3)

3 (1.9)

 

5%

30 (26.5)

58 (37.4)

 

 10%

22 (19.5)

23 (14.8)

 

 15%

16 (14.2)

19 (12.3)

 

 20%

11 (9.7)

11 (7.1)

 

 50%

1 (0.9)

7 (4.5)

 

 I do not know

27 (23.9)

34 (22)

 

Are orphan drugs reimbursed in Poland?

  

0

 Yes

2 (1.8)

4 (2.6)

 

Yes, some

50 (44.3)

83 (53.6)

 

 No

15 (13.3)

46 (29.7)

 

 I do not know

46 (40.7)

22 (14.2)

 

Do RD constitute a serious public health issue?

  

0.0001

 Absolutely yes

29 (25.7)

83 (53.5)

 

 Yes

67 (59.3)

61 (39.4)

 

 No

6 (5.3)

6 (3.9)

 

 Definitely not

1 (0.9)

0

 

 I do not know

10 (8.8)

5 (3.2)

Â